Zoltán Fehérvári

7.6k total citations · 3 hit papers
89 papers, 6.1k citations indexed

About

Zoltán Fehérvári is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Zoltán Fehérvári has authored 89 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 13 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Zoltán Fehérvári's work include Immune Cell Function and Interaction (25 papers), T-cell and B-cell Immunology (21 papers) and Immunotherapy and Immune Responses (11 papers). Zoltán Fehérvári is often cited by papers focused on Immune Cell Function and Interaction (25 papers), T-cell and B-cell Immunology (21 papers) and Immunotherapy and Immune Responses (11 papers). Zoltán Fehérvári collaborates with scholars based in United States, Japan and United Kingdom. Zoltán Fehérvári's co-authors include Shimon Sakaguchi, Tomoyuki Yamaguchi, Takashi Nomura, Yasushi Onishi, Kajsa Wing, Makoto Miyara, Masahiro Ono, Ruka Setoguchi, Jun Shimizu and Haruhiko Yagi and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Zoltán Fehérvári

84 papers receiving 6.0k citations

Hit Papers

CTLA-4 Control over Foxp3... 2006 2026 2012 2019 2008 2006 2008 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CTLA-4 Control over Foxp3 + Regulatory T Cell Function
    2008 2.3k citations Kajsa Wing, Yasushi Onishi et al. Science profile →
  2. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
    2006 1.3k citations Shimon Sakaguchi, Masahiro Ono et al. Immunological Reviews profile →
  3. Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturation
    2008 555 citations Yasushi Onishi, Zoltán Fehérvári et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Zoltán Fehérvári 4.7k 1.4k 655 636 372 89 6.1k
Valérie Dardalhon 3.9k 0.8× 1.2k 0.9× 594 0.9× 1.3k 2.0× 386 1.0× 45 5.8k
Masahito Kamanaka 3.6k 0.8× 624 0.4× 520 0.8× 740 1.2× 723 1.9× 29 5.2k
Linda M. Bradley 5.2k 1.1× 1.0k 0.7× 879 1.3× 1.1k 1.8× 782 2.1× 97 7.3k
Julia A. Brown 4.1k 0.9× 1.6k 1.1× 316 0.5× 573 0.9× 702 1.9× 37 6.2k
Maria‐Grazia Roncarolo 4.4k 0.9× 1.3k 0.9× 614 0.9× 736 1.2× 686 1.8× 59 6.0k
Michael Lohoff 4.4k 0.9× 1.1k 0.7× 271 0.4× 844 1.3× 624 1.7× 88 6.1k
Mike Bigler 4.4k 0.9× 832 0.6× 536 0.8× 498 0.8× 510 1.4× 20 5.6k
Shomyseh Sanjabi 3.0k 0.7× 1.4k 1.0× 346 0.5× 1.7k 2.7× 401 1.1× 32 5.5k
Wendy T. Watford 4.4k 0.9× 1.3k 0.9× 453 0.7× 1.6k 2.5× 606 1.6× 58 6.3k
Rob Kastelein 4.0k 0.9× 1.3k 0.9× 526 0.8× 1.3k 2.0× 1.0k 2.7× 38 6.4k

Countries citing papers authored by Zoltán Fehérvári

Since Specialization
Citations

This map shows the geographic impact of Zoltán Fehérvári's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoltán Fehérvári with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoltán Fehérvári more than expected).

Fields of papers citing papers by Zoltán Fehérvári

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoltán Fehérvári. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoltán Fehérvári. The network helps show where Zoltán Fehérvári may publish in the future.

Co-authorship network of co-authors of Zoltán Fehérvári

This figure shows the co-authorship network connecting the top 25 collaborators of Zoltán Fehérvári. A scholar is included among the top collaborators of Zoltán Fehérvári based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoltán Fehérvári. Zoltán Fehérvári is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fehérvári, Zoltán. (2021). Intranasal vaccination. Nature Immunology. 22(9). 1071–1071. 8 indexed citations
2.
Fehérvári, Zoltán. (2019). Mechanisms of colonization resistance. 5 indexed citations
3.
Fehérvári, Zoltán. (2019). Vaccine sex differences. Nature Immunology. 20(2). 111–111. 4 indexed citations
4.
Fehérvári, Zoltán. (2019). Proving kinetic proofreading. Nature Immunology. 20(6). 665–665. 1 indexed citations
5.
Fehérvári, Zoltán. (2018). Crisis management. Nature Immunology. 19(6). 510–510. 1 indexed citations
6.
Fehérvári, Zoltán. (2018). Antibiotics–immune system interactions. Nature Immunology. 19(2). 99–99. 2 indexed citations
7.
Fehérvári, Zoltán. (2018). Targeting cancer by Siglecs. Nature Immunology. 19(11). 1148–1148. 2 indexed citations
8.
Fehérvári, Zoltán. (2018). Mast cells in autoimmune disease. Nature Immunology. 19(4). 316–316. 6 indexed citations
9.
Fehérvári, Zoltán. (2017). Assaulting the microbiota. Nature Immunology. 19(1). 1–1. 1 indexed citations
10.
Nagahama, Kanji, Zoltán Fehérvári, Takatoku Oida, et al.. (2009). Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance. International Immunology. 21(4). 379–391. 21 indexed citations
11.
Wing, Kajsa, Yasushi Onishi, Tomoyuki Yamaguchi, et al.. (2008). CTLA-4 Control over Foxp3 + Regulatory T Cell Function. Science. 322(5899). 271–275. 2260 indexed citations breakdown →
12.
Zaccone, Paola, Zoltán Fehérvári, Jenny M. Phillips, David W. Dunne, & Anne Cooke. (2006). Parasitic worms and inflammatory diseases. Parasite Immunology. 28(10). 515–523. 137 indexed citations
13.
Fehérvári, Zoltán, Tomoyuki Yamaguchi, & Shimon Sakaguchi. (2006). The dichotomous role of IL-2: tolerance versus immunity. Trends in Immunology. 27(3). 109–111. 60 indexed citations
14.
Fehérvári, Zoltán & Shimon Sakaguchi. (2006). Peacekeepers of the Immune System. Scientific American. 295(4). 56–63. 6 indexed citations
15.
Sakaguchi, Shimon, Masahiro Ono, Ruka Setoguchi, et al.. (2006). Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease. Immunological Reviews. 212(1). 8–27. 1270 indexed citations breakdown →
16.
Wing, Kajsa, Zoltán Fehérvári, & Shimon Sakaguchi. (2006). Emerging possibilities in the development and function of regulatory T cells. International Immunology. 18(7). 991–1000. 123 indexed citations
17.
Fehérvári, Zoltán & Shimon Sakaguchi. (2004). CD4+ Tregs and immune control. Journal of Clinical Investigation. 114(9). 1209–1217. 323 indexed citations
18.
Fehérvári, Zoltán. (2004). Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. International Immunology. 16(12). 1769–1780. 183 indexed citations
19.
Zaccone, Paola, Zoltán Fehérvári, Frances M. Jones, et al.. (2003). Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. European Journal of Immunology. 33(5). 1439–1449. 249 indexed citations
20.
Phillips, Jenny M., et al.. (2000). Nondepleting Anti-CD4 Has an Immediate Action on Diabetogenic Effector Cells, Halting Their Destruction of Pancreatic β Cells. The Journal of Immunology. 165(4). 1949–1955. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Dardalhon Breakdown of academic impact, for papers by Masahito Kamanaka Breakdown of academic impact, for papers by Linda M. Bradley Breakdown of academic impact, for papers by Julia A. Brown Breakdown of academic impact, for papers by Maria‐Grazia Roncarolo Breakdown of academic impact, for papers by Michael Lohoff Breakdown of academic impact, for papers by Mike Bigler Breakdown of academic impact, for papers by Shomyseh Sanjabi Breakdown of academic impact, for papers by Wendy T. Watford Breakdown of academic impact, for papers by Rob Kastelein
Rankless by CCL
2026